Bryostatin 1 in Treating Patients With Ovarian Epithelial Cancer
Status:
Completed
Trial end date:
2003-05-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients who
have ovarian epithelial cancer that has not responded to previous chemotherapy.